Sionna Therapeutics (NASDAQ:SION) Shares Gap Up – Should You Buy?

Sionna Therapeutics, Inc. (NASDAQ:SION) gapped up before the market opened on Thursday . The stock had previously closed at $13.88, but opened at $14.18. Sionna Therapeutics shares last traded at $13.87, with a volume of 4,394 shares traded.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on SION. Stifel Nicolaus began coverage on shares of Sionna Therapeutics in a report on Tuesday, March 4th. They set a “buy” rating and a $32.00 price objective for the company. Guggenheim started coverage on shares of Sionna Therapeutics in a research report on Tuesday, March 4th. They issued a “buy” rating and a $45.00 target price on the stock. Finally, TD Cowen started coverage on shares of Sionna Therapeutics in a research report on Tuesday, March 4th. They issued a “buy” rating on the stock.

Sionna Therapeutics Stock Performance

Sionna Therapeutics (NASDAQ:SION) last released its quarterly earnings data on Thursday, March 20th. The company reported ($3.38) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.68) by ($0.70).

About Sionna Therapeutics

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.